Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. - Wikidata - wikimedia - TriplyDB

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

http://www.wikidata.org/entity/Q34543818

about

Long term hormone therapy for perimenopausal and postmenopausal women Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Long-term hormone therapy for perimenopausal and postmenopausal women.Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis.Menstrual cycle-related exacerbation of disease Occult breast tumor reservoir: biological properties and clinical significance.Ductal carcinoma in situ of the breast: a surgical perspective.Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.The 2012 hormone therapy position statement of: The North American Menopause Society.Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know?Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.IMS updated recommendations on postmenopausal hormone therapy.The Mammary Glands of Macaques Hormone therapy and fatal breast cancer.A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization Memory Impairment in Estrogen Receptor α Knockout Mice Through Accumulation of Amyloid-β Peptides.Impact of risk-reducing salpingo-oophorectomy in premenopausal women.Is HRT justified for symptom management in women at higher risk of developing breast cancer?Current breast cancer risks of hormone replacement therapy in postmenopausal women.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.Hormone therapy and breast cancer risk.Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.Postmenopausal hormone therapy and cardiovascular disease in perspective.The tissue selective estrogen complex: a promising new menopausal therapy Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.Is there evidence that estrogen therapy promotes weight maintenance via effects on leptin?Sex hormones and lipoprotein(a) concentration.HRT in difficult circumstances: are there any absolute contraindications?Hormone replacement therapy and the risk of breast cancer.Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.Postmenopausal hormone therapy: risks and benefits.

P2860

Q24201974-FB9941C4-A9AB-45B5-BB06-4D15ADD1EC10 Q24658109-C52CDA57-7B85-4E44-B92C-7D09AE6BC2BA Q30238978-92B7F654-BDEE-4B3B-8A02-44AD242A5EA3 Q30239742-8ECF4C1C-1FDC-4BDA-A1E9-C9988B803AB3 Q30431992-6D44B978-F254-4EBF-946A-EC1135D46EFE Q30456637-7ABC1D8D-0CA6-4882-88D6-66A7FA2411AF Q30463534-25147BCA-E983-4329-812B-BD99B0FDA687 Q30474007-AA31E36C-DE2C-4DF3-92E7-CEEDE34C86FF Q34161400-0938F7A2-7833-45EC-941C-AA97128EF418 Q34285969-F0E6FF37-B72B-4805-B9A2-59F12112F2CD Q34490225-2037657C-3025-4400-B370-85B145BC8F71 Q34626471-CF90E00C-6FB7-46A1-B946-005E324636BC Q34762947-B2193BFE-9BC3-4A9B-AC83-005BFCFB17C1 Q34994476-F58ADABF-4210-4274-9869-B225E5DCA446 Q35035445-45F080F5-A5C7-4338-9C17-EC58935A739D Q35092002-37C8D35A-2C84-48EC-A6D1-0C67E8096868 Q35634204-8C8052B8-97E6-4D56-B8C5-3CD89DCCC27C Q35657905-A6A4FB87-80D7-4265-82CF-A633E94DD5DC Q35859830-C0B6B1E1-641F-45B7-9F41-1EB32E178847 Q35878258-1B6D2D7C-3A69-4035-B31F-01FE8DA1A6BA Q36372962-49C7698D-9D0B-4FEE-BAAE-DAC618919428 Q36645276-E765CC0C-2942-4B78-8D23-070EC106F3A4 Q36675379-89589678-FCB3-43DE-8862-DB649E00F17B Q36781520-3109E55A-1BCE-42D2-93E1-3E0BC3F6117B Q36896822-E189F326-CD0D-480A-AB2E-8462E9B08260 Q36939490-F024B96A-D3B1-433A-9918-62294EEE01C0 Q36946798-EF851009-65FF-4CC8-9003-96663600E0A6 Q36970351-5884B800-BFC3-464D-9935-E7C7A60DCDEA Q37014593-7C1075C9-FEDD-48E0-BC42-51A6C394743D Q37048294-26D19475-A895-4068-BB82-51830ABFD471 Q37163009-829C20B2-C07B-4D42-87BA-1909E519D6D3 Q37234323-90A51290-05C0-49D7-9DD2-807DDCCE03FB Q37277298-BA7249C2-5FDE-4C83-B83E-62C4E423578F Q37480990-855649AC-34F8-402B-A73C-360DC7AB4203 Q37669667-AA0CA462-EE4A-4444-A4A0-7EB31DF2285C Q37825893-8B10BFCF-1C62-4161-ADD0-2FB80A5077BA Q37847568-EBD2480D-28A6-458D-82AA-0676C15E1B79 Q37909897-85554F4C-E94F-4415-BBB1-875EB5B18F04 Q37989179-B4037916-61CC-4D31-894D-6418AAC49AE7 Q38082563-A882F6E2-94AD-4794-B7F9-C832746AFEE4

P2860

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

http://www.wikidata.org/entity/Q34543818

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@ast

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@en

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@nl

type

label

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@ast

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@en

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@nl

prefLabel

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@ast

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@en

Prior hormone therapy and brea ...... al of estrogen plus progestin.

@nl

P1433

Q34543818-B10304E1-D1EA-4D42-ADD8-34F9643AE146

P1476

Q34543818-0F84D4F9-B50C-46B1-8B2F-BDA43F8193EA

P2093

Q34543818-0D99B352-95DF-4F7C-AD6B-9F1A04810719

Q34543818-15EA85F5-A5C4-4587-8260-73A6837EF396

Q34543818-1B5E175C-9037-46DA-944A-BF582CE2B33C

Q34543818-37F46202-AE15-4BBA-A644-EA11686C3270

Q34543818-47968661-6812-4708-8FF7-BCE13900BDA7

Q34543818-55C88FD3-423F-43FF-B47F-C78FDCE7225E

Q34543818-627E3A24-554C-4882-95DC-04FAAE92D1E8

Q34543818-6D1DA86B-829E-4019-9BD3-918DA278383A

Q34543818-7C1F7538-B45A-44D2-A4EE-70B97BAFF732

Q34543818-8D17A0A2-02D4-425D-816E-1DC8E62FD932

P304

Q34543818-341C130F-A214-455A-8B7C-63357DE3B8C0

P31

Q34543818-EF461ED3-10D6-4D2F-B68C-9A8A2F7FF608

P356

Q34543818-8CE522CB-2CE1-4366-8119-F4ACD23B4837

P433

Q34543818-58C82E95-6D2C-4989-8D2F-6D7AE82ECE69

P478

Q34543818-37DBAF95-5097-4E5F-ABCF-70E08E0A85A1

P50

Q34543818-18FAB2A6-B8CF-447F-9220-4A3190280FA6

Q34543818-59CC709B-68CE-43FD-AED3-411373742B00

Q34543818-D209B376-703C-4C94-BD22-C483BE4E353B

Q34543818-DE2C9839-14DC-4B49-BEFD-C79ECCD86044

P577

Q34543818-E0BD8A67-703A-435C-9387-B6B131E61783

P5875

Q34543818-63116B19-F55D-42B7-B27A-8DF8D2B39FE1

P698

Q34543818-0010FA69-07AB-49AD-8DD7-EAD5FA88BF33

P356

J.MATURITAS.2006.05.004

P1433

P1476

Prior hormone therapy and brea ...... ial of estrogen plus progestin

@en

P2093

Anita Aggerwal

http://www.w3.org/2001/XMLSchema#string

Anne McTiernan

http://www.w3.org/2001/XMLSchema#string

Dorothy S Lane

http://www.w3.org/2001/XMLSchema#string

F Allan Hubbell

http://www.w3.org/2001/XMLSchema#string

J David Curb

http://www.w3.org/2001/XMLSchema#string

Jacques E Rossouw

http://www.w3.org/2001/XMLSchema#string

Jamardan Khandekar

http://www.w3.org/2001/XMLSchema#string

JoNell Potter

http://www.w3.org/2001/XMLSchema#string

Norman Lasser

http://www.w3.org/2001/XMLSchema#string

Rebecca J Rodabough

http://www.w3.org/2001/XMLSchema#string

P304

103-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MATURITAS.2006.05.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Garnet L Anderson

Cheryl Ritenbaugh

Ana Maria Lopez

Karen L. Margolis

P577

2006-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6968515

http://www.w3.org/2001/XMLSchema#string

P698

16815651

http://www.w3.org/2001/XMLSchema#string